Why ISO 22196 appears on blanket specs, and why buyers should qualify it early
The real buying question is not whether a blanket "kills germs" in general use. It is whether a finished 250gsm brushed polyester microfiber blanket shows measurable antibacterial activity against named bacteria on the tested surface under a defined laboratory method, and whether that evidence supports narrow claim wording for a senior-care textile.
ISO 22196 was developed for plastics and other non-porous surfaces. Its use on pile textiles is exceptional, not routine. If a lab applies ISO 22196 to a blanket face, buyers should require a written suitability rationale from the testing laboratory stating why the specific surface and specimen preparation were appropriate for that method. Without that written justification, treat the method choice as a commercial risk.
For many blankets, ISO 20743 is the better route because it is the textile antibacterial standard. It includes textile-specific test principles based on absorption and transfer behaviour, rather than assuming the contact conditions of a hard surface. If a supplier jumps from an ISO 22196 report to broad health, hygiene or infection-control claims, treat that as a red flag rather than added value.
Passing ISO 22196 or ISO 20743 does not demonstrate antiviral efficacy, infection prevention, reduced cross-contamination, safer resident outcomes, or lower healthcare-associated infection risk. Those claims sit outside what these antibacterial textile or surface methods prove.
Method choice: ISO 22196 versus ISO 20743 on a 250gsm microfiber blanket
A typical blanket in this weight band is 100% polyester, usually warp knit or circular knit, brushed and sheared to about 240-260gsm finished weight. Method choice should follow the finished article surface: pile height, shearing depth, calendering, softener level, resin finish, coating, lamination, and face/back asymmetry all affect whether the test set-up is technically credible.
Use ISO 22196 only where the exact tested face behaves more like a smooth finished surface than a conventional absorbent pile textile, and where the lab confirms in writing why the method remains suitable. A tightly sheared microfiber face with a polymer-rich surface finish may sometimes be testable this way. A lofty, absorbent, open-pile or strongly textured face usually points away from ISO 22196.
Within ISO 20743, buyers should ask which test principle was used. The standard includes routes based on absorption and transfer behaviour, commonly described through absorption-type, transfer-type or printing-type approaches depending on how bacteria are introduced and recovered from the textile. Method selection should be laboratory-justified against the blanket's actual surface behaviour, not chosen by habit.
Do not rely on buyer-side heuristics such as 'it looks smooth enough' or 'it has a coating, so ISO 22196 is fine'. The correct control is article-specific laboratory validation. If the programme is commercially important, require the lab to explain method suitability for the tested construction, face orientation and finish version.
If marketing insists on antibacterial messaging for a borderline construction, one practical route is to request both ISO 20743 and the proposed ISO 22196 method during development, then keep only the claim supported by the better article-specific evidence. That is more defensible than letting sales artwork dictate the test method.
Construction details that can change method fit and claim scope
Small process changes can alter antibacterial test relevance. A deeper brush raises loft and absorbency. More aggressive shearing can compact the face. Silicone or fatty softeners can change wetting and bacterial transfer. A resin finish can reduce absorbency. A back coating or laminate can make one side behave very differently from the other.
Specify the tested face orientation in the tech pack: face A only, face B only, or both. If only one face is treated and tested, packaging and online copy must not imply the whole blanket is uniformly antibacterial. This matters on asymmetric constructions such as smooth-face microfiber with a softer raised reverse.
If a laminate or coating is involved, separate the claim clearly: is the antibacterial performance claimed on the laminate surface, the textile face, or the assembled blanket article? Those are different substrates. Buyers should not accept one report and assume it covers all three.
Typical production controls for this construction might include finished GSM 250gsm ±5%, cut size tolerance around ±2cm on a 130x170cm blanket, and face appearance locked to an approved handfeel standard. Any move from low-shear to higher loft, from one softener package to another, or from uncoated to coated construction is enough to trigger revalidation if antibacterial claims remain in scope.
For adjacent construction issues on bulk blankets, it helps to review normal quality controls alongside the treated-article claim, not instead of it. See blanket quality-control inspection and AQL 2.5 inspection checklist.
Finish chemistry: what buyers can ask without pretending to be the formulator
Buyers should ask the supplier to disclose the chemistry family and application route even if the full formula stays proprietary. Common routes include silver-based systems, quaternary ammonium compound systems, zinc-based systems such as zinc oxide, and other organic packages fixed with a binder.
Do not rank silver, QAC or zinc from brochure language alone. Evaluate article-level controls instead: pre-wash result, post-wash retention, handfeel change, shade shift, crocking risk, odour, cure sensitivity, and realistic cost delta. On pale goods, some systems can slightly affect whiteness or cast. Binder-heavy systems can improve fixation but may stiffen the hand or reduce drape if overdosed.
Commercially, QAC systems are often lower cost but can be more sensitive to detergent system, cationic softener interaction or repeated harsh laundering. Silver systems may retain performance better in some constructions but usually at a higher chemical cost. Zinc-based packages are often positioned around freshness or odour-control claims, which should not be inflated into stronger antibacterial messaging without the relevant article data.
Lock the approved treatment version into the specification: chemistry family, nominal add-on or supplier code, cure window, and application route. If the supplier changes chemical vendor, binder system, add-on target or cure profile, require re-approval and normally retesting on the actual article.
How to read an ISO 22196 or ISO 20743 report properly
A usable report should identify the method, testing laboratory, report date, test organisms, article code, sample description, tested face, and whether the specimen was unwashed or pre-washed. For antibacterial reports, buyers should expect an actual result metric such as an antibacterial activity value or a log reduction, not just a vague 'pass'. If the report only states 'effective' or 'meets requirements', ask for the numerical worksheet.
Common organisms on these reports include Staphylococcus aureus and Escherichia coli. Contact or incubation periods are often around 18-24 hours, depending on the method and laboratory protocol. Buyers should check whether the result is reported before wash only or after defined laundering cycles as well.
For ISO 22196 used on a textile, require the lab's written statement on method suitability: why the tested blanket face was appropriate, how the specimen was prepared, how contact conditions were maintained, and whether the result applies to the face tested only or to the assembled article claim.
For ISO 20743, ask which route was selected and why: absorption-based or transfer-based behaviour is the key distinction. The right answer depends on the finished article surface, not the generic fibre content.
Check accreditation carefully. A general ISO/IEC 17025 claim is not enough by itself. Verify that the accreditation scope covers the exact method and the exact test site that issued the report. That is a standard sourcing check, similar to how buyers verify other textile performance reports such as ISO 105 C06 wash-fastness testing or anti-pilling test requirements.
Report matching: bulk approval fails here more often than buyers expect
The report should match the finished sale article, not a similar base fabric. At minimum, match the article code, treatment version, manufacturing site, construction, GSM range, shade or colour family, and tested face orientation. If the supplier cannot show that linkage, the evidence is weak even if the result number looks strong.
Also match the sample form. A report on greige or lab-finished fabric does not automatically support claims on a sewn blanket with overlocked edges, lockstitch hems, quilting, binding, printing, post-sew washing or packed retail presentation. Any post-finish operation that changes surface chemistry or face exposure can affect claim scope.
For senior-care programmes, require the supplier to state whether the tested sample was finished fabric or finished sewn blanket. If the retail or institutional article includes seams, quilting lines, bound edges, embroidery or printed panels, decide whether the claim is for the treated face area only or for the delivered blanket article. That distinction should appear in the technical file and in artwork review.
A practical commercial rule is this: if the tested specimen does not match the approved bulk article in construction, site, treatment version or face orientation, do not carry the claim forward unchanged. Re-test or downgrade the claim.
Finished fabric versus sewn-blanket testing
Finished fabric testing is useful during development because it is faster and cheaper. It helps screen chemistry options, cure windows and initial performance. For a 250gsm microfiber programme, that can be enough to narrow treatment candidates before bulk.
Sewn-blanket testing matters when the claim is attached to the retail-ready article or the institutional SKU actually shipped. Seams, quilting, edge binding, embroidery, patches, ultrasonic lines, bar tacks, compression packing and post-sew heat exposure may alter face availability, finish distribution or the proportion of untreated components.
If the blanket has edge binding, overlock thread, woven labels, zipper pockets, quilted sections or multi-panel construction, decide whether those components are inside or outside claim scope. A buyer should not assume a fabric-swatches report covers the whole article uniformly.
A practical sourcing sequence is: development on finished fabric, then final claim confirmation on the finished sewn blanket from pilot or first bulk lot. That keeps lab cost sensible while reducing the risk of a claim that only existed on a swatch.
Evidence review: accept, query or reject
Accept evidence where the report names the blanket article code, treatment version, factory site, tested face, organisms, numerical pre-wash result, and numerical post-wash result if durability is claimed. The sample should be production-representative finished fabric or finished blanket, and the wash protocol should be stated clearly.
Query evidence where the report is on a similar construction but not the sold article, where shade is missing, where only one face was tested but artwork implies both sides, where laundering conditions are vague, or where the supplier relies on a chemical-supplier certificate instead of article-level test data.
Reject evidence where there is no article code, no treatment version, no tested face, no wash-retention data despite a durability claim, no lab suitability rationale for ISO 22196 on a textile, or no link between tested specimen and approved bulk. If evidence fails, treat the blanket as untreated for claim purposes and manage the order through normal quality controls and packaging controls such as blanket care washing guide and custom blanket lead times and shipping.
Wash-retention protocol: what to write into the PO
Do not write vague language such as 'washable antibacterial' into the purchase order. Tie the retained-performance requirement to the exact care conditions likely in use: detergent type, wash temperature, liquor ratio where relevant, tumble-dry or line-dry condition, and number of cycles.
A practical PO format is: test method required; organisms required; face tested; pre-wash result threshold; post-wash result threshold; laundering method; cycle count; and whether approval is on finished fabric or sewn blanket. Example: ISO 20743 or approved alternative justified by the lab; S. aureus and E. coli; face A only; report on finished sewn blanket; laundering to ISO 6330 at the specified care regime; post-wash result after 10 or 20 cycles according to the claim sold.
Senior-care buyers should align cycle count to actual use. For lighter-duty resident throws washed at domestic-equivalent conditions, 10 cycles may be a basic retained-performance checkpoint. For heavier reuse, rental or repeated institutional laundering, 20-30 cycles may be more appropriate. The point is not picking the biggest number for marketing. The point is matching the likely service condition.
State the detergent and drying assumptions. For example: non-chlorine detergent, no cationic softener unless normal use includes it, wash at 40°C or 60°C as sold on the care label, and tumble dry low if that is the intended care route. If the programme will face industrial laundering, specify that separately and do not rely on a domestic wash-retention report.
If the care label changes after testing, or if the buyer changes from line dry to tumble dry, from 40°C to 60°C, or from neutral detergent to a harsher chemistry, re-check durability. Wash-retention claims are only as good as the care conditions they actually represent. For related care-label controls, see ISO 3758 care labeling.
Procurement checklist and PO clause set
A procurement-ready checklist should cover at least these points: method required; lab suitability rationale if ISO 22196 is used on a textile; organisms required; face orientation tested; finished fabric or sewn blanket; pre-wash threshold; post-wash threshold; laundering method and cycle count; claim wording allowed; and retest triggers.
Useful retest triggers include change of treatment vendor, chemistry family, binder system, add-on target, cure profile, manufacturing site, face construction, brushing level, shearing depth, softener package, laminate/coating status, shade family if it affects process, or care-label condition.
A workable PO clause can read along these lines: 'Supplier shall provide article-specific antibacterial test report on approved sale article code, treatment version, shade family, manufacturing site and tested face orientation. Method selection for textile article shall be laboratory-justified in writing. Report shall state organism set, numerical result metric, laundering protocol, cycle count and sample form. Any process or material change affecting treatment or surface state requires buyer approval and may trigger retest.'
Keep marketing language narrow. Safe wording is usually limited to the treated article or treated surface under lab test conditions. Block broader phrases such as 'prevents infection', 'stops viruses', 'safer for residents', or 'reduces cross-contamination' unless separate evidence and regulatory review support them.
Commercial reality: claim control is part of quality control
For a senior-care blanket, antibacterial evidence is only one part of approval. Buyers still need the basics: GSM tolerance, size tolerance, seam security, shade control, pilling expectation, care-label accuracy, and AQL plan. A technically valid lab report does not rescue a blanket with unstable bulk finishing or poor sewing consistency.
On microfiber constructions around 250gsm, common bulk controls include pilling review after agreed laundering, seam integrity at hems or overlock, and face consistency lot to lot. If the antibacterial finish changes handfeel or pile lay, keep a sealed approval standard and compare bulk against it during pre-shipment inspection.
If the programme is packed for retail or healthcare distribution, make sure the claim printed on belly bands, inserts or cartons matches the tested scope exactly. Claim drift between lab report, tech pack and packaging copy is one of the most common avoidable failures in treated-article sourcing.
The safest commercial position is simple: test the right article, by the right method, under the right wash conditions, and say only what the evidence actually supports.
Frequently asked
Can ISO 22196 be used on a 250gsm microfiber blanket? Sometimes, but only exceptionally. ISO 22196 is designed for plastics and other non-porous surfaces, not typical pile textiles. If a supplier uses ISO 22196 on a microfiber blanket, require a written laboratory rationale explaining why the exact tested face and specimen preparation were suitable. Without that justification, ISO 20743 is usually the safer textile route.
What should I expect to see on the report result? Ask for a numerical antibacterial result such as an antibacterial activity value or log reduction, not just 'pass' or 'effective'. The report should also identify the article code, tested face, organisms, washed or unwashed status, and the laundering protocol if wash durability is claimed.
Does passing ISO 22196 or ISO 20743 prove antiviral performance or infection prevention? No. These methods support narrow antibacterial claims under laboratory conditions. They do not prove antiviral efficacy, infection prevention, reduced cross-contamination, or safer outcomes for residents or patients.
Should I approve testing on fabric only, or on the sewn blanket? Use finished fabric testing during development to screen options, then confirm the claim on the finished sewn blanket if the claim will be attached to the shipped SKU. Seams, binding, quilting, embroidery and post-sew finishing can affect claim scope and article representativeness.
What wash-retention condition should go into the PO? Tie it to likely real use: method, organisms, tested face, wash standard such as ISO 6330, detergent type, temperature, drying condition, and cycle count. Ten cycles may be enough for a basic retained-performance claim on lighter use; 20 to 30 cycles may be more realistic for repeated institutional reuse. The key is matching the care condition actually expected in service.
What should trigger retesting? Retest if the treatment vendor, chemistry family, binder system, add-on target, cure profile, factory site, face construction, brushing level, shearing depth, softener package, laminate status, or care-label condition changes. Also retest if the claim scope expands from one face to both faces, or from fabric to finished article.
Have a project in mind? Send us your spec — we'll reply within one business day with indicative pricing and a sample plan.